Autoimmune Disease: When Defence Turns Inward

Autoimmune disease is not simply a strong or weak immune system. It involves loss of control over selected self directed responses. Diagnosis requires a clinical pattern, because symptoms and autoantibody tests are rarely decisive alone.

Autoimmunity and autoimmune disease are not identical Immune tolerance limits harmful responses against the body's own molecules, called self antigens. It uses several controls rather than one perfect self recognition switch. Some self reactive immune cells and small amounts of autoantibodies can exist without causing illness. Autoimmunity means that an immune response recognises a self antigen. Autoimmune disease develops when self directed immune activity contributes to clinically important tissue injury, altered organ function or both. This distinction prevents a positive antibody result from being mistaken for a diagnosis. Self tolerance uses several safeguards Self tolerance includes controls during immune cell development and after those cells enter the circulation and tissues. Some strongly self reactive cells are removed. Others are switched off, restrained by regulatory cells or prevented from receiving the signals needed for activation. Autoimmune disease can develop when several safeguards fail or become insufficient. It is rarely explained by one immune cell suddenly mistaking the whole body for an invader. The exact initiating events remain uncertain for most autoimmune diseases. Tissue harm can happen through different mechanisms Self reactive T cells can damage target cells directly or activate other inflammatory cells. B cells can produce autoantibodies. Some autoantibodies damage cells, form inflammatory immune complexes, block a receptor or stimulate it inappropriately. Complement proteins, cytokines and innate immune responses can amplify the process. Their importance differs between diseases and between people with the same diagnosis. Autoantibodies are therefore not the only mechanism. Some are useful disease markers without being the main cause of tissue damage. Organ specific and systemic are useful descriptions An organ specific autoimmune disease has an immune target concentrated mainly in one organ or tissue. Type 1 diabetes mainly targets insulin producing beta cells in the pancreas. The consequences can still affect the whole body because insulin is essential for controlling blood glucose. A systemic autoimmune disease can affect several organs or tissues. Systemic lupus erythematosus, called SLE, can involve skin, joints, blood cells, kidneys, lungs, heart or nervous system. These categories are useful but not absolute boxes. Some mainly organ specific diseases have wider effects, and systemic diseases vary greatly between individuals. Causes are usually multifactorial Most autoimmune diseases arise through interactions between inherited susceptibility and several biological or environmental influences. Age, sex related biology, infections, medicines, smoking and other exposures can matter in particular diseases. The evidence and strength of each association vary. A suspected trigger does not prove why one person developed the condition. Many exposed people never develop disease, while some cases have no identifiable trigger. Autoimmune disease is not caused by a personal failure to manage stress, diet or lifestyle. Flares, remission, activity and damage are different A flare is a clinically important increase in disease activity. The definition and severity thresholds depend on the specific condition. Remission means that disease activity is absent or very low according to an agreed definition. It does not always mean cure or that treatment can stop. Disease activity describes the immune mediated process now. Accumulated damage describes lasting change caused by earlier disease, treatment or another complication. Symptoms do not always track activity closely. Fatigue or pain can persist because of damage, sleep problems, medicine effects, infection or another condition. New symptoms in someone with autoimmune disease should therefore not automatically be labelled a flare. There is no universal autoimmune blood test Diagnosis combines what the person describes, the examination, organ specific tests and selected immune tests. The useful combination differs between diseases. An autoantibody is an antibody that recognises one of the body's own molecules. Its presence can support a diagnosis when the clinical pattern fits. Antinuclear antibodies, called ANA, recognise components associated with cell nuclei. ANA testing is useful when there is reasonable suspicion of SLE or a related condition. A positive ANA result does not diagnose autoimmune disease. Healthy people, infections, medicines and other conditions can also produce a positive result. A negative ANA makes untreated active SLE less likely, but it does not exclude every autoimmune disease. Other autoimmune conditions use different tests and criteria. Treatment depends on the disease and the damage Some treatments reduce or redirect immune activity. These include corticosteroids, conventional immunosuppressants and targeted biological medicines in selected diseases. Treatment can also replace lost function. People with type 1 diabetes need insulin because damaged beta cells no longer provide enough of it. Other care may relieve symptoms, protect an organ, prevent blood clots, support rehabilitation or manage permanent damage. Medicines that alter immunity can increase infection risk and require monitoring. Fever or worsening illness should not be assumed to be an autoimmune flare. The aim is usually to control activity, prevent damage and preserve function while limiting treatment harm. A systemic lupus example An adult reports joint pain, mouth ulcers, a sun sensitive rash and persistent fatigue. They later develop ankle swelling and unusually frothy urine. This pattern raises concern about a systemic condition, but each feature has several possible causes. The clinician checks blood pressure and urine because kidney involvement can initially cause few obvious symptoms. Blood counts, kidney function and selected immune tests may also be needed. ANA is requested because the clinical pattern creates reasonable suspicion. The result is interpreted with more specific tests and the wider assessment. The clinician also considers infection, medicine effects, thrombosis and unrelated kidney disease. These can mimic disease activity or occur alongside it. Taking part in the assessment Describe the timing, pattern and functional effect of symptoms. Mention rashes, joint swelling, mouth ulcers, fevers, urinary changes, chest symptoms and neurological changes when present. Ask what findings suggest autoimmune disease and which alternatives remain. Ask what each blood or urine test can and cannot establish. Do not start, stop or increase steroid or immune modifying treatment without clinical advice. A sudden change can cause harm or mask infection. Call 999 for severe breathing difficulty, chest tightness or heaviness, sudden confusion, blue or grey skin, or collapse. This lesson explains general autoimmune biology. It cannot diagnose an autoimmune disease or interpret an autoantibody result for you.

Autoimmune disease requires more than self reactive cells or a positive antibody test. Harm can involve T cells, autoantibodies, immune complexes and other pathways. Diagnosis and treatment must match the clinical pattern and affected organs.